MCMCR Neuroscience & Alzheimer’s Institute is an independent Alzheimer’s-focused clinical research center in Miami, Florida. The institute participates in national research collaborations, including leadership representation within the Alzheimer’s Clinical Trial Consortium (ACTC).
We conduct biomarker-driven and disease-modifying clinical trials spanning preclinical and early symptomatic stages of Alzheimer’s disease, supported by infusion infrastructure, CSF collection, advanced neuroimaging partnerships, and experienced research personnel.
We integrate scientific rigor with community-based recruitment to deliver high-quality data in modern Alzheimer’s clinical research.
Dr. Caro leads biomarker-driven and disease-modifying Alzheimer’s clinical trials across preclinical and early symptomatic stages. He oversees infusion-based protocols, lumbar puncture procedures (CSF collection), and the institute’s overall clinical operations.
Dr. Melgar provides clinical oversight and community-based recruitment leadership across ongoing Alzheimer’s clinical trials, supporting high-quality study execution and participant care.
Have questions? Here are answers to some of the most common questions about our clinical trials.
You can speak with our team to see if a current study matches your health profile.
A staff member explains the study, reviews your health history, and answers all questions.
Our team follows strict clinical research standards to ensure every participant’s safety.
Study timelines vary based on the condition and treatment being evaluated.
Support research that offers a path to new treatment possibilities.
Stay connected with Melgar-Caro Medcenter and contribute to advancements in healthcare and community research.
Copyright 2025 – MCMCR.NET. Created by Digital Auxilius.
